243 related articles for article (PubMed ID: 21864343)
1. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania.
Shekalaghe SA; Drakeley C; van den Bosch S; ter Braak R; van den Bijllaardt W; Mwanziva C; Semvua S; Masokoto A; Mosha F; Teelen K; Hermsen R; Okell L; Gosling R; Sauerwein R; Bousema T
Malar J; 2011 Aug; 10():247. PubMed ID: 21864343
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan.
El-Sayed B; El-Zaki SE; Babiker H; Gadalla N; Ageep T; Mansour F; Baraka O; Milligan P; Babiker A
PLoS One; 2007 Dec; 2(12):e1311. PubMed ID: 18074034
[TBL] [Abstract][Full Text] [Related]
4. Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.
Khatib RA; Skarbinski J; Njau JD; Goodman CA; Elling BF; Kahigwa E; Roberts JM; MacArthur JR; Gutman JR; Kabanywanyi AM; Smith EE; Somi MF; Lyimo T; Mwita A; Genton B; Tanner M; Mills A; Mshinda H; Bloland PB; Abdulla SM; Kachur SP
Malar J; 2012 Apr; 11():140. PubMed ID: 22545573
[TBL] [Abstract][Full Text] [Related]
5. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.
Shekalaghe S; Drakeley C; Gosling R; Ndaro A; van Meegeren M; Enevold A; Alifrangis M; Mosha F; Sauerwein R; Bousema T
PLoS One; 2007 Oct; 2(10):e1023. PubMed ID: 17925871
[TBL] [Abstract][Full Text] [Related]
6. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
[TBL] [Abstract][Full Text] [Related]
7. Primaquine for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
[TBL] [Abstract][Full Text] [Related]
8. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
[TBL] [Abstract][Full Text] [Related]
9. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
[TBL] [Abstract][Full Text] [Related]
10. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2014 Jun; (6):CD008152. PubMed ID: 24979199
[TBL] [Abstract][Full Text] [Related]
11. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission.
Morris U; Msellem MI; Mkali H; Islam A; Aydin-Schmidt B; Jovel I; Shija SJ; Khamis M; Ali SM; Hodzic L; Magnusson E; Poirot E; Bennett A; Sachs MC; Tarning J; Mårtensson A; Ali AS; Björkman A
BMC Med; 2018 Dec; 16(1):215. PubMed ID: 30526588
[TBL] [Abstract][Full Text] [Related]
12. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia.
von Seidlein L; Walraven G; Milligan PJ; Alexander N; Manneh F; Deen JL; Coleman R; Jawara M; Lindsay SW; Drakeley C; De Martin S; Olliaro P; Bennett S; Schim van der Loeff M; Okunoye K; Targett GA; McAdam KP; Doherty JF; Greenwood BM; Pinder M
Trans R Soc Trop Med Hyg; 2003; 97(2):217-25. PubMed ID: 14584381
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Arango EM; Upegui YA; Carmona-Fonseca J
Acta Trop; 2012 May; 122(2):177-82. PubMed ID: 22245668
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
Cisse B; Cairns M; Faye E; NDiaye O; Faye B; Cames C; Cheng Y; NDiaye M; Lô AC; Simondon K; Trape JF; Faye O; NDiaye JL; Gaye O; Greenwood B; Milligan P
PLoS One; 2009 Sep; 4(9):e7164. PubMed ID: 19784374
[TBL] [Abstract][Full Text] [Related]
16. Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP.
Kolaczinski K; Leslie T; Ali I; Durrani N; Lee S; Barends M; Beshir K; Ord R; Hallett R; Rowland M
PLoS One; 2012; 7(1):e28957. PubMed ID: 22303437
[TBL] [Abstract][Full Text] [Related]
17. Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes.
Shah NK; Schapira A; Juliano JJ; Srivastava B; MacDonald PD; Poole C; Anvikar A; Meshnick SR; Valecha N; Mishra N
Antimicrob Agents Chemother; 2013 Jul; 57(7):2948-54. PubMed ID: 23587943
[TBL] [Abstract][Full Text] [Related]
18. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
Graves PM; Choi L; Gelband H; Garner P
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008152. PubMed ID: 29393511
[TBL] [Abstract][Full Text] [Related]
19. Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan.
Hamid MMA; Thriemer K; Elobied ME; Mahgoub NS; Boshara SA; Elsafi HMH; Gumaa SA; Hamid T; Abdelbagi H; Basheir HM; Marfurt J; Chen I; Gosling R; Price RN; Ley B
Malar J; 2018 Mar; 17(1):117. PubMed ID: 29548285
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.
Huho BJ; Killeen GF; Ferguson HM; Tami A; Lengeler C; Charlwood JD; Kihonda A; Kihonda J; Kachur SP; Smith TA; Abdulla SM
Malar J; 2012 Apr; 11():118. PubMed ID: 22513162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
